Hadassah Researchers Helping to Enhance Immunotherapy

March 1, 2024

Hadassah Researchers Helping to Enhance Immunotherapy

Researchers at the Hadassah-Hebrew University Medical Center, together with research groups in other medical institutions around the world, are cooperating in efforts to better determine those cancer patients who can benefit from personalized immunotherapy treatment.

Considered a major advance in cancer treatment, immunotherapy boosts the patient’s own immune system to attack cancer cells precisely and selectively. Such treatments can preclude the need for chemotherapy and even biopsies.

Read the full story in The Jerusalem Post about how researchers are identifying biomarkers that will help predict success.

Read More

Hadassah Excels in Cancer Research and Treatment
Hadassah’s Experimental Multiple Myeloma Treatment Has Nearly Perfect Results
Hadassah to Debut Proton Therapy in Israel
Organoids Help Personalize Treatment for Cancer Patients at Hadassah
Hadassah On Call Podcast: Closing in on a Cure for Cancer

No items found.